-
1
-
-
80053344963
-
The "Million hearts" initiative: Preventing heart attacks and strokes
-
Frieden TR, Berwick DM. The "Million Hearts" initiative: preventing heart attacks and strokes. N Engl J Med. 2011; 365(13):e27.
-
(2011)
N Engl J Med.
, vol.365
, Issue.13
, pp. e27
-
-
Frieden, T.R.1
Berwick, D.M.2
-
2
-
-
77952326558
-
Deaths preventable in the U.S. by improvements in use of clinical preventive services
-
Farley TA, Dalal MA, Mostashari F, Frieden TR. Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med. 2010; 38(6):600-609.
-
(2010)
Am J Prev Med.
, vol.38
, Issue.6
, pp. 600-609
-
-
Farley, T.A.1
Dalal, M.A.2
Mostashari, F.3
Frieden, T.R.4
-
3
-
-
84937469509
-
Paying for prevention: A novel test of medicare value-based payment for cardiovascular risk reduction
-
Sanghavi DM, Conway PH. Paying for prevention: a novel test of Medicare value-based payment for cardiovascular risk reduction. JAMA. 2015; 314(2):123-124.
-
(2015)
JAMA
, vol.314
, Issue.2
, pp. 123-124
-
-
Sanghavi, D.M.1
Conway, P.H.2
-
5
-
-
72949097216
-
How canwe support the use of systematic reviews in policymaking?
-
Lavis JN. How canwe support the use of systematic reviews in policymaking? PLoS Med. 2009; 6(11):e1000141.
-
(2009)
PLoS Med.
, vol.6
, Issue.11
, pp. e1000141
-
-
Lavis, J.N.1
-
6
-
-
84866945196
-
The evolution of a new publication type: Steps and challenges of producing overviews of reviews
-
Thomson D, Russell K, Becker L, Klassen T, Hartling L. The evolution of a new publication type: steps and challenges of producing overviews of reviews. Res Synth Methods. 2010; 1(3-4):198-211.
-
(2010)
Res Synth Methods
, vol.1
, Issue.3-4
, pp. 198-211
-
-
Thomson, D.1
Russell, K.2
Becker, L.3
Klassen, T.4
Hartling, L.5
-
7
-
-
84919364147
-
The benefits and challenges of conducting an overview of systematic reviews in public health: A focus on physical activity
-
Baker PR, Costello JT, Dobbins M, Waters EB. The benefits and challenges of conducting an overview of systematic reviews in public health: a focus on physical activity. J Public Health (Oxf). 2014; 36(3):517-521.
-
(2014)
J Public Health (Oxf)
, vol.36
, Issue.3
, pp. 517-521
-
-
Baker, P.R.1
Costello, J.T.2
Dobbins, M.3
Waters, E.B.4
-
9
-
-
39049184922
-
Multiple risk factor interventions for primary prevention of coronary heart disease
-
Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev. 2011; (1):CD001561.
-
(2011)
Cochrane Database Syst Rev.
, Issue.1
, pp. CD001561
-
-
Ebrahim, S.1
Taylor, F.2
Ward, K.3
Beswick, A.4
Burke, M.5
Davey Smith, G.6
-
10
-
-
33847606952
-
Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews
-
Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007; 7:10.
-
(2007)
BMC Med Res Methodol.
, vol.7
, pp. 10
-
-
Shea, B.J.1
Grimshaw, J.M.2
Wells, G.A.3
-
11
-
-
84876197996
-
Overview of systematic reviews of the effectiveness of reminders in improving healthcare professional behavior
-
Cheung A, Weir M, Mayhew A, Kozloff N, Brown K, Grimshaw J. Overview of systematic reviews of the effectiveness of reminders in improving healthcare professional behavior. Syst Rev. 2012; 1: 36.
-
(2012)
Syst Rev.
, vol.1
, pp. 36
-
-
Cheung, A.1
Weir, M.2
Mayhew, A.3
Kozloff, N.4
Brown, K.5
Grimshaw, J.6
-
12
-
-
79551512111
-
Methodology inconductinga systematic review of systematic reviews of healthcare interventions
-
Smith V, Devane D, Begley CM, Clarke M. Methodology inconductinga systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011; 11(1):15.
-
(2011)
BMC Med Res Methodol.
, vol.11
, Issue.1
, pp. 15
-
-
Smith, V.1
Devane, D.2
Begley, C.M.3
Clarke, M.4
-
13
-
-
43049113533
-
GRADE: An emerging consensus on rating quality of evidence and strength of recommendations
-
Guyatt GH, Oxman AD, Vist GE, et al.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-926.
-
(2008)
BMJ
, vol.336
, Issue.7650
, pp. 924-926
-
-
Guyatt, G.H.1
Oxman, A.D.2
Vist, G.E.3
-
14
-
-
65849268320
-
Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials
-
Baigent C, Blackwell L, Collins R, et al.; Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009; 373(9678):1849-1860.
-
(2009)
Lancet.
, vol.373
, Issue.9678
, pp. 1849-1860
-
-
Baigent, C.1
Blackwell, L.2
Collins, R.3
-
15
-
-
79960200973
-
Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: A meta-analysis of randomized trials
-
Berger JS, Lala A, Krantz MJ, Baker GS, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials. Am Heart J. 2011; 162(1):115-24.e2.
-
(2011)
Am Heart J.
, vol.162
, Issue.1
, pp. 115-242
-
-
Berger, J.S.1
Lala, A.2
Krantz, M.J.3
Baker, G.S.4
Hiatt, W.R.5
-
16
-
-
30944467297
-
Aspirin for the primary prevention of cardiovascular events in women and men: A sex-specific meta-analysis of randomized controlled trials
-
Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006; 295(3): 306-313.
-
(2006)
JAMA
, vol.295
, Issue.3
, pp. 306-313
-
-
Berger, J.S.1
Roncaglioni, M.C.2
Avanzini, F.3
Pangrazzi, I.4
Tognoni, G.5
Brown, D.L.6
-
17
-
-
84939995659
-
A systematic review of aspirin in primary prevention: Is it time for a new approach?
-
Brotons C, Benamouzig R, Filipiak KJ, Limmroth V, Borghi C. A systematic review of aspirin in primary prevention: is it time for a new approach? Am J Cardiovasc Drugs. 2015; 15(2):113-133.
-
(2015)
Am J Cardiovasc Drugs
, vol.15
, Issue.2
, pp. 113-133
-
-
Brotons, C.1
Benamouzig, R.2
Filipiak, K.J.3
Limmroth, V.4
Borghi, C.5
-
18
-
-
79953246984
-
Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: A systematic review and meta-analysis
-
Butalia S, Leung AA, Ghali WA, Rabi DM. Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol. 2011; 10:25.
-
(2011)
Cardiovasc Diabetol.
, vol.10
, pp. 25
-
-
Butalia, S.1
Leung, A.A.2
Ghali, W.A.3
Rabi, D.M.4
-
19
-
-
72249095825
-
Aspirin for the primary prevention of cardiovascular events: A systematic review and meta-analysis comparing patients with and without diabetes
-
Calvin AD, Aggarwal NR, Murad MH, et al. Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes. Diabetes Care. 2009; 32(12):2300-2306.
-
(2009)
Diabetes Care
, vol.32
, Issue.12
, pp. 2300-2306
-
-
Calvin, A.D.1
Aggarwal, N.R.2
Murad, M.H.3
-
20
-
-
71749105108
-
Aspirin for primary prevention of cardiovascular events in people with diabetes: Meta-analysis of randomised controlled trials
-
De Berardis G, Sacco M, Strippoli GF, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ. 2009; 339:b4531.
-
(2009)
BMJ
, vol.339
, pp. b4531
-
-
De Berardis, G.1
Sacco, M.2
Strippoli, G.F.3
-
21
-
-
79959345305
-
Effect of aspirin on mortality in the primary prevention of cardiovascular disease
-
Raju N, Sobieraj-Teague M, Hirsh J, O'Donnell M, Eikelboom J. Effect of aspirin on mortality in the primary prevention of cardiovascular disease. Am J Med. 2011; 124(7):621-629.
-
(2011)
Am J Med.
, vol.124
, Issue.7
, pp. 621-629
-
-
Raju, N.1
Sobieraj-Teague, M.2
Hirsh, J.3
O'Donnell, M.4
Eikelboom, J.5
-
22
-
-
84865457524
-
The aspirin controversy in primary prevention
-
Raju NC, Eikelboom JW. The aspirin controversy in primary prevention. Curr Opin Cardiol. 2012; 27(5):499-507.
-
(2012)
Curr Opin Cardiol.
, vol.27
, Issue.5
, pp. 499-507
-
-
Raju, N.C.1
Eikelboom, J.W.2
-
23
-
-
84857376799
-
Effect of aspirin on vascular and nonvascular outcomes: Meta-analysis of randomized controlled trials
-
Seshasai SR, Wijesuriya S, Sivakumaran R, et al. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med. 2012; 172(3):209-216.
-
(2012)
Arch Intern Med.
, vol.172
, Issue.3
, pp. 209-216
-
-
Seshasai, S.R.1
Wijesuriya, S.2
Sivakumaran, R.3
-
24
-
-
78651266855
-
Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
-
Stavrakis S, Stoner JA, Azar M, Wayangankar S, Thadani U. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. Am J Med Sci. 2011; 341(1):1-9.
-
(2011)
Am J Med Sci.
, vol.341
, Issue.1
, pp. 1-9
-
-
Stavrakis, S.1
Stoner, J.A.2
Azar, M.3
Wayangankar, S.4
Thadani, U.5
-
25
-
-
84885136577
-
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: A systematic review and overview of reviews
-
Sutcliffe P, Connock M, Gurung T, et al. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews. Health Technol Assess. 2013; 17(43):1-253.
-
(2013)
Health Technol Assess
, vol.17
, Issue.43
, pp. 1-253
-
-
Sutcliffe, P.1
Connock, M.2
Gurung, T.3
-
26
-
-
84891918487
-
Aspirin in primary prevention of cardiovascular disease and cancer: A systematic review of the balance of evidence from reviews of randomized trials
-
Sutcliffe P, Connock M, Gurung T, et al. Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials. PLoS One. 2013; 8(12):e81970.
-
(2013)
PLoS One
, vol.8
, Issue.12
, pp. e81970
-
-
Sutcliffe, P.1
Connock, M.2
Gurung, T.3
-
27
-
-
62549131608
-
Aspirin for the primary prevention of cardiovascular events: An update of the evidence for the US preventive services task force
-
Wolff T, Miller T, Ko S. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2009; 150(6):405-410.
-
(2009)
Ann Intern Med.
, vol.150
, Issue.6
, pp. 405-410
-
-
Wolff, T.1
Miller, T.2
Ko, S.3
-
28
-
-
77952685474
-
Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A meta-analysis
-
Younis N, Williams S, Ammori B, Soran H. Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis. Expert Opin Pharmacother. 2010; 11(9):1459-1466.
-
(2010)
Expert Opin Pharmacother.
, vol.11
, Issue.9
, pp. 1459-1466
-
-
Younis, N.1
Williams, S.2
Ammori, B.3
Soran, H.4
-
29
-
-
74449086639
-
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
-
Zhang C, Sun A, Zhang P, et al. Aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract. 2010; 87(2):211-218.
-
(2010)
Diabetes Res Clin Pract.
, vol.87
, Issue.2
, pp. 211-218
-
-
Zhang, C.1
Sun, A.2
Zhang, P.3
-
31
-
-
84859327058
-
Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: Systematic review and multiple treatments meta-analysis
-
Fretheim A, Odgaard-Jensen J, Brørs O, et al. Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis. BMC Med. 2012; 10:33.
-
(2012)
BMC Med.
, vol.10
, pp. 33
-
-
Fretheim, A.1
Odgaard-Jensen, J.2
Brørs, O.3
-
32
-
-
67650082354
-
Use ofblood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
-
Law MR, Morris JK, Wald NJ. Use ofblood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338:b1665.
-
(2009)
BMJ
, vol.338
, pp. b1665
-
-
Law, M.R.1
Morris, J.K.2
Wald, N.J.3
-
33
-
-
84922753787
-
Effects of blood pressure reduction in mild hypertension: A systematic review and meta-analysis
-
Sundström J, Arima H, Jackson R, et al.; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med. 2015; 162(3):184-191.
-
(2015)
Ann Intern Med.
, vol.162
, Issue.3
, pp. 184-191
-
-
Sundström, J.1
Arima, H.2
Jackson, R.3
-
34
-
-
85019356296
-
The benefits of statin therapy in patients without established cardiovascular disease but with cardiovascular risk factors: Meta-analysis of randomized controlled trials
-
Brugts JJ, Yetgin T, Hoeks SE, et al. The benefits of statin therapy in patients without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomized controlled trials. Eur Heart J. 2009; 30: 510-511.
-
(2009)
Eur Heart J.
, vol.30
, pp. 510-511
-
-
Brugts, J.J.1
Yetgin, T.2
Hoeks, S.E.3
-
35
-
-
77952061696
-
Statins for primary prevention of cardiovascular mortality in women: A systematic review and meta-analysis
-
Bukkapatnam RN, Gabler NB, Lewis WR. Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis. Prev Cardiol. 2010; 13(2):84-90.
-
(2010)
Prev Cardiol.
, vol.13
, Issue.2
, pp. 84-90
-
-
Bukkapatnam, R.N.1
Gabler, N.B.2
Lewis, W.R.3
-
36
-
-
84857064061
-
Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: A meta-analysis
-
Chen YH, Feng B, Chen ZW. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis. Exp Clin Endocrinol Diabetes. 2012; 120(2):116-120.
-
(2012)
Exp Clin Endocrinol Diabetes
, vol.120
, Issue.2
, pp. 116-120
-
-
Chen, Y.H.1
Feng, B.2
Chen, Z.W.3
-
37
-
-
84933673677
-
Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174,000 participants in 27 randomised trials
-
Fulcher J, O'Connell R, Voysey M, et al.; Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015; 385(9976):1397-1405.
-
(2015)
Lancet.
, vol.385
, Issue.9976
, pp. 1397-1405
-
-
Fulcher, J.1
O'Connell, R.2
Voysey, M.3
-
38
-
-
84864832599
-
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials
-
Mihaylova B, Emberson J, Blackwell L, et al.; Cholesterol Treatment Trialists' (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012; 380(9841):581-590.
-
(2012)
Lancet.
, vol.380
, Issue.9841
, pp. 581-590
-
-
Mihaylova, B.1
Emberson, J.2
Blackwell, L.3
-
39
-
-
33646829645
-
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: Meta-analysis of randomised controlled trials
-
Costa J, Borges M, David C, Vaz Carneiro A. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ. 2006; 332 (7550):1115-1124.
-
(2006)
BMJ
, vol.332
, Issue.7550
, pp. 1115-1124
-
-
Costa, J.1
Borges, M.2
David, C.3
Vaz Carneiro, A.4
-
40
-
-
85058197556
-
Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis [abstract]
-
Costanzo P, Perrone-Filardi P, Petretta M, et al. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis [abstract]. J Am Coll Cardiol. 2009; 53(10):A210.
-
(2009)
J Am Coll Cardiol.
, vol.53
, Issue.10
, pp. A210
-
-
Costanzo, P.1
Perrone-Filardi, P.2
Petretta, M.3
-
41
-
-
84871202527
-
Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: A meta-analysis
-
de Vries FM, Denig P, Pouwels KB, Postma MJ, Hak E. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis. Drugs. 2012; 72(18): 2365-2373.
-
(2012)
Drugs
, vol.72
, Issue.18
, pp. 2365-2373
-
-
De Vries, F.M.1
Denig, P.2
Pouwels, K.B.3
Postma, M.J.4
Hak, E.5
-
42
-
-
55949096863
-
Primary prevention of cardiovascular mortality and events with statin treatments: A network meta-analysis involving more than 65,000 patients
-
Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol. 2008; 52(22): 1769-1781.
-
(2008)
J Am Coll Cardiol.
, vol.52
, Issue.22
, pp. 1769-1781
-
-
Mills, E.J.1
Rachlis, B.2
Wu, P.3
Devereaux, P.J.4
Arora, P.5
Perri, D.6
-
43
-
-
70749087459
-
Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
-
Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis. Int J Cardiol. 2010; 138(1): 25-31.
-
(2010)
Int J Cardiol.
, vol.138
, Issue.1
, pp. 25-31
-
-
Petretta, M.1
Costanzo, P.2
Perrone-Filardi, P.3
Chiariello, M.4
-
44
-
-
77954179995
-
Statins and all-cause mortality in high-risk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65,229 participants
-
Ray KK, Seshasai SR, Erqou S, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med. 2010; 170(12):1024-1031.
-
(2010)
Arch Intern Med.
, vol.170
, Issue.12
, pp. 1024-1031
-
-
Ray, K.K.1
Seshasai, S.R.2
Erqou, S.3
-
46
-
-
33751507008
-
Primary prevention of cardiovascular diseases with statin therapy: A meta-analysis of randomized controlled trials
-
Thavendiranathan P, Bagai A, Brookhart MA, Choudhry NK. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006; 166(21):2307-2313.
-
(2006)
Arch Intern Med.
, vol.166
, Issue.21
, pp. 2307-2313
-
-
Thavendiranathan, P.1
Bagai, A.2
Brookhart, M.A.3
Choudhry, N.K.4
-
48
-
-
84891791619
-
Pharmacological interventions for smoking cessation: An overview and network meta-analysis
-
Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013; 5:CD009329.
-
(2013)
Cochrane Database Syst Rev.
, vol.5
, pp. CD009329
-
-
Cahill, K.1
Stevens, S.2
Perera, R.3
Lancaster, T.4
-
50
-
-
85042045862
-
Population-based smoking cessation strategies: A summary of a select group of evidence-based reviews
-
Health Quality Ontario. Population-based smoking cessation strategies: a summary of a select group of evidence-based reviews. Ont Health Technol Assess Ser. 2010; 10(1):1-44.
-
(2010)
Ont Health Technol Assess Ser.
, vol.10
, Issue.1
, pp. 1-44
-
-
-
51
-
-
0029914622
-
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
-
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17(1):1-12.
-
(1996)
Control Clin Trials
, vol.17
, Issue.1
, pp. 1-12
-
-
Jadad, A.R.1
Moore, R.A.2
Carroll, D.3
-
52
-
-
0032417075
-
The delphi list: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by delphi consensus
-
Verhagen AP, de Vet HC, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998; 51(12):1235-1241.
-
(1998)
J Clin Epidemiol.
, vol.51
, Issue.12
, pp. 1235-1241
-
-
Verhagen, A.P.1
De Vet, H.C.2
De Bie, R.A.3
-
53
-
-
84919346036
-
Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: A randomized clinical trial
-
Ikeda Y, Shimada K, Teramoto T, et al. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial. JAMA. 2014; 312(23):2510-2520.
-
(2014)
JAMA
, vol.312
, Issue.23
, pp. 2510-2520
-
-
Ikeda, Y.1
Shimada, K.2
Teramoto, T.3
-
54
-
-
84893863909
-
Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: A record linkage study
-
McConnachie A, Walker A, Robertson M, et al. Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study. Eur Heart J. 2014; 35(5):290-298.
-
(2014)
Eur Heart J.
, vol.35
, Issue.5
, pp. 290-298
-
-
McConnachie, A.1
Walker, A.2
Robertson, M.3
|